02/14/2025
7:25 PM | FORWARD VENTURES V LP (Filed by)
Viracta Therapeutics, Inc. (Subject)
Viracta Therapeutics (Subject)
| Form SCHEDULE 13G | |
02/05/2025
4:00 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2025
4:14 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2024
3:39 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/29/2024
4:14 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
3:06 PM | Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
3:08 PM | ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
4:20 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:33 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Viracta Therapeutics, Inc. (Subject)
Viracta Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
6:30 AM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:46 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
5:10 PM | Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
5:13 PM | ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:15 AM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2024
6:47 PM | Murphy Samuel Lafayette (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:48 PM | Chung Jane (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:49 PM | Borellini Flavia (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:50 PM | ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:39 PM | Rubino Stephen (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:40 PM | Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:43 PM | Barlow Jane F (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:44 PM | Simon Barry J. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
6:46 PM | DARCY THOMAS E (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy VIRX Stock Free VIRX Stock Alerts